Cargando…
A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer.
Overexpression of cyclin D1 is frequently found in various types of human tumours and results from clonal rearrangement and/or amplification involving chromosomal region 11q13. In order to evaluate the pathological relevance of cyclin D1 overexpression in human breast cancer, we generated a polyclon...
Autores principales: | Michalides, R., Hageman, P., van Tinteren, H., Houben, L., Wientjens, E., Klompmaker, R., Peterse, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074376/ https://www.ncbi.nlm.nih.gov/pubmed/8611372 |
Ejemplares similares
-
Cyclin A is a prognostic indicator in early stage breast cancer with and without tamoxifen treatment
por: Michalides, R, et al.
Publicado: (2002) -
Overexpressions of Cyclin B1, cdc2, p16 and p53 in Human Breast Cancer: The Clinicopathologic Correlations and Prognostic Implications
por: Chae, Seoung Wan, et al.
Publicado: (2011) -
P53 codon 11, 72, and 248 gene polymorphisms in endometriosis
por: Hsieh, Yao-Yuan, et al.
Publicado: (2006) -
Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters
por: Mohammedi, Latifa, et al.
Publicado: (2019) -
Association of MicroRNA-21 with p53 at Mutant Sites R175H and R248Q, Clinicopathological Features, and Prognosis of NSCLC
por: Zhou, Yaodong, et al.
Publicado: (2020)